TrialBritish journal of cancer2007

A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV.

S Steinbild et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.